Nestlé, Seres Therapeutics collaborate on microbiome therapy
Nestlé Health Science has signed an exclusive agreement outside the United States and Canada for Seres Therapeutics’ novel class of microbiome therapeutics (Ecobiotics) in the fields of Clostridium difficile infections … Continue Reading →